Loring Wolcott & Coolidge Fiduciary Advisors LLP Amgen Inc Transaction History

Loring Wolcott & Coolidge Fiduciary Advisors LLP

  • $11.2 Billion
  • Q3 2025

A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Amgen Inc stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 57,459 shares of AMGN stock, worth $19.6 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
57,459
Previous 59,923 4.11%
Holding current value
$19.6 Million
Previous $16.7 Million 3.09%
% of portfolio
0.14%
Previous 0.15%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025
SELL
$271.18 - $309.22 $668,187 - $761,918
-2,464 Reduced 4.11%
57,459 $16.2 Million
Q2 2025

Jul 30, 2025
SELL
$262.28 - $309.85 $667,764 - $788,878
-2,546 Reduced 4.08%
59,923 $16.7 Million
Q1 2025

Apr 24, 2025
SELL
$258.59 - $327.36 $612,341 - $775,188
-2,368 Reduced 3.65%
62,469 $19.5 Million
Q4 2024

Jan 28, 2025
SELL
$258.78 - $328.31 $61,589 - $78,137
-238 Reduced 0.37%
64,837 $16.9 Million
Q3 2024

Oct 25, 2024
SELL
$309.38 - $337.38 $279,370 - $304,654
-903 Reduced 1.37%
65,075 $21 Million
Q2 2024

Jul 17, 2024
SELL
$262.75 - $319.31 $746,735 - $907,479
-2,842 Reduced 4.13%
65,978 $20.6 Million
Q1 2024

Apr 23, 2024
SELL
$268.87 - $324.56 $547,419 - $660,804
-2,036 Reduced 2.87%
68,820 $19.6 Million
Q4 2023

Feb 01, 2024
SELL
$255.7 - $288.46 $233,198 - $263,075
-912 Reduced 1.27%
70,856 $20.4 Million
Q3 2023

Nov 03, 2023
BUY
$218.65 - $271.46 $127,472 - $158,261
583 Added 0.82%
71,768 $19.3 Million
Q2 2023

Aug 01, 2023
SELL
$214.27 - $253.37 $1.79 Million - $2.12 Million
-8,374 Reduced 10.53%
71,185 $15.8 Million
Q1 2023

May 02, 2023
SELL
$225.79 - $275.2 $1.08 Million - $1.32 Million
-4,804 Reduced 5.69%
79,559 $19.2 Million
Q4 2022

Mar 02, 2023
SELL
$229.03 - $291.01 $23,132 - $29,392
-101 Reduced 0.12%
84,363 $22.2 Million
Q4 2022

Feb 14, 2023
SELL
$229.03 - $291.01 $1.84 Million - $2.34 Million
-8,051 Reduced 8.7%
84,464 $22 Million
Q3 2022

Oct 25, 2022
SELL
$224.46 - $253.15 $46,238 - $52,148
-206 Reduced 0.22%
92,515 $20.9 Million
Q2 2022

Jul 26, 2022
SELL
$230.71 - $256.74 $533,170 - $593,326
-2,311 Reduced 2.43%
92,721 $22.6 Million
Q1 2022

Apr 13, 2022
BUY
$219.27 - $242.57 $483,490 - $534,866
2,205 Added 2.38%
95,032 $23 Million
Q4 2021

Feb 14, 2022
BUY
$198.88 - $227.6 $322,782 - $369,394
1,623 Added 1.78%
92,827 $20.9 Million
Q3 2021

Nov 12, 2021
BUY
$212.27 - $248.7 $845,471 - $990,572
3,983 Added 4.57%
91,204 $19.4 Million
Q2 2021

Aug 13, 2021
BUY
$233.58 - $259.14 $679,250 - $753,579
2,908 Added 3.45%
87,221 $21.3 Million
Q1 2021

Apr 14, 2021
BUY
$221.91 - $258.6 $929,137 - $1.08 Million
4,187 Added 5.23%
84,313 $21 Million
Q4 2020

Jan 14, 2021
SELL
$216.38 - $257.67 $17,094 - $20,355
-79 Reduced 0.1%
80,126 $18.4 Million
Q3 2020

Oct 15, 2020
SELL
$234.65 - $260.95 $348,455 - $387,510
-1,485 Reduced 1.82%
80,205 $20.4 Million
Q2 2020

Jul 30, 2020
SELL
$197.81 - $242.74 $52,815 - $64,811
-267 Reduced 0.33%
81,690 $19.3 Million
Q1 2020

Apr 15, 2020
SELL
$182.24 - $241.7 $1.11 Million - $1.47 Million
-6,070 Reduced 6.9%
81,957 $16.6 Million
Q4 2019

Jan 22, 2020
BUY
$189.21 - $243.2 $1.88 Million - $2.42 Million
9,947 Added 12.74%
88,027 $21.2 Million
Q3 2019

Nov 05, 2019
SELL
$174.11 - $208.62 $1.99 Million - $2.38 Million
-11,421 Reduced 12.76%
78,080 $15.1 Million
Q2 2019

Aug 09, 2019
SELL
$166.7 - $195.41 $509,601 - $597,368
-3,057 Reduced 3.3%
89,501 $16.5 Million
Q1 2019

Apr 08, 2019
SELL
$180.87 - $203.88 $835,981 - $942,333
-4,622 Reduced 4.76%
92,558 $17.6 Million
Q4 2018

Feb 13, 2019
SELL
$178.4 - $208.25 $40,318 - $47,064
-226 Reduced 0.23%
97,180 $18.9 Million
Q3 2018

Oct 31, 2018
SELL
$185.29 - $208.89 $18,714 - $21,097
-101 Reduced 0.1%
97,406 $20.2 Million
Q2 2018

Aug 07, 2018
SELL
$166.05 - $186.51 $136,991 - $153,870
-825 Reduced 0.84%
97,507 $18 Million
Q1 2018

Apr 20, 2018
BUY
$169.43 - $198.0 $343,434 - $401,346
2,027 Added 2.1%
98,332 $16.8 Million
Q4 2017

Feb 08, 2018
BUY
$168.79 - $188.59 $919,905 - $1.03 Million
5,450 Added 6.0%
96,305 $16.7 Million
Q3 2017

Oct 27, 2017
BUY
$167.29 - $191.0 $774,050 - $883,757
4,627 Added 5.37%
90,855 $16.9 Million
Q2 2017

Aug 07, 2017
BUY
N/A
86,228
86,228 $0

Others Institutions Holding AMGN

# of Institutions
3,269
Shares Held
428M
Call Options Held
6.17M
Put Options Held
5.85M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Loring Wolcott & Coolidge Fiduciary Advisors LLP Portfolio

Follow Loring Wolcott & Coolidge Fiduciary Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email